Research Output per year
Fingerprint Dive into the research topics where Giuseppe Cicero is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 19 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status
Cicero, G., Unti, E., Dieli, F., Lo Presti, E., Meraviglia, S., Di Stefano, A. B., Mocciaro, F., Unti, E., Pecoraro, G., Conte, E., Scibetta, N., Di Mitri, R., Conte, E., Mocciaro, F., Pecoraro, G. M. & Di Mitri, R., 2019, In : Journal of Crohn's and Colitis. p. 1-11 11 p.Research output: Contribution to journal › Article
Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life
Profita, G., De Luca, R. & Cicero, G., 2019, In : OncoTargets and Therapy. 12, p. 1621-1627 7 p.Research output: Contribution to journal › Article
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy
Vella, M., Serretta, V., Cangemi, A., Cicero, G., Sanfilippo, C., Abrate, A., Scalici Gesolfo, C. & Barresi, E., 2018, In : Urology Annals. 10, p. 280-286 7 p.Research output: Contribution to journal › Article
Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
De Luca, R., Cicero, G., Gristina, V., Blasi, L. & Alù, M., 2018, In : Drug Design, Development and Therapy. 12, p. 1769-1775 7 p.Research output: Contribution to journal › Article
Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer
De Luca, R., Dieli, F. & Cicero, G., 2018, In : OncoTargets and Therapy. 11, p. 3059-3063 5 p.Research output: Contribution to journal › Article